RB
IRD

Richmond Brothers’s Opus Genetics IRD Stock Holding History

Richmond Brothers’s Portfolio IRD Stock Details IRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-155,620
Closed -$204K – 36
2024
Q3 		$204K Sell
155,620
-35,684
-19% -$54.9K 0.13% 32
2024
Q2 		$293K Sell
191,304
-36,157
-16% -$62.5K 0.58% 17
2024
Q1 		$457K Sell
227,461
-25,308
-10% -$64.2K 0.85% 15
2023
Q4 		$761K Sell
252,769
-115,234
-31% -$341K 1.33% 10
2023
Q3 		$1.23M Buy
368,003
+26,143
+8% +$105K 2.32% 9
2023
Q2 		$1.48M Buy
341,860
+1,334
+0.4% +$6.33K 2.4% 10
2023
Q1 		$1.28M Buy
340,526
+11,556
+4% +$41.5K 2.15% 9
2022
Q4 		$1.16M Buy
328,970
+8,638
+3% +$22.7K 1.63% 10
2022
Q3 		$641K Buy
320,332
+9,212
+3% +$19.9K 0.71% 16
2022
Q2 		$597K Buy
311,120
+186,576
+150% +$424K 0.61% 16
2022
Q1 		$403K Buy
124,544
+50,124
+67% +$172K 0.31% 21
2021
Q4 		$277K Buy
+74,420
New +$298K 0.2% 24

Other funds holding IRD

BCM
BIOS Capital Management Fort Worth, Texas $52.9M AUM 30.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
KPWS
Kestra Private Wealth Services Austin, Texas $9.1B AUM 32.09% 1-Year Est. Return

Richmond Brothers's IRD Position: Q4 2024 in Review

Richmond Brothers sold out of Opus Genetics (IRD) in Q4 2024, closing a stake of 155,620 shares — an estimated $204K sold.

Richmond Brothers first reported a position in IRD in Q4 2021 and held it in 12 quarters. The position peaked at $1.48M in Q2 2023. 43 funds tracked by Wall St. Rank hold IRD as of Q4 2024.

  • Richmond Brothers reported no remaining Opus Genetics position as of Q4 2024 after selling out during the quarter.
  • Richmond Brothers sold 155,620 Opus Genetics shares in Q4 2024, an estimated $204K.
  • Richmond Brothers first reported a position in Opus Genetics in Q4 2021 and held it in 12 quarters.
  • Richmond Brothers's Opus Genetics position peaked at $1.48M in Q2 2023.
  • 43 funds tracked by Wall St. Rank held Opus Genetics as of Q4 2024.

Based on Richmond Brothers's 13F filing for Q4 2024, filed 11 Feb 2025.